Finance

Lists
Why is HPHA down 5,83%?
Dive Deeper
HPHA:FRA
Heidelberg Pharma AG
2,10 €
-5,83%
(-0,13) 1D
12 қаз., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HPHA...
Open
2,23 €
High
2,23 €
Low
2,10 €
Mkt. cap
98,25 млн
Avg. vol.
447,00
Volume
0,00
52-wk high
3,33 €
52-wk low
2,10 €
EPS
-0,71 €
No. of employees
41
Open
2,23 €
High
2,23 €
Low
2,10 €
Mkt. cap
98,25 млн
Avg. vol.
447,00
Volume
0,00
52-wk high
3,33 €
52-wk low
2,10 €
EPS
-0,71 €
No. of employees
41
News stories
From web sources and news partners
About Heidelberg Pharma AG
CEO-
Employees41
Founded1997
Headquarters-
Sector-
Websiteheidelberg-pharma.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 ж. там.
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
Revenue
47,13 мың
21,44 мың
3,03 млн
4,34 млн
Cost of goods sold
86,71 мың
90,34 мың
374,20 м.
380,12 м.
Cost of revenue
86,71 мың
90,34 мың
374,20 м.
380,12 м.
Research and development expenses
7,59 млн
17,74 млн
6,07 млн
2,27 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,56 млн
2,61 млн
1,57 млн
1,21 млн
Operating expense
10,07 млн
22,12 млн
7,76 млн
3,82 млн
Total operating expenses
10,16 млн
22,21 млн
8,13 млн
4,20 млн
Operating income
-10,11 млн
-22,19 млн
-5,10 млн
144,28 м.
Other non operating income
1,41 млн
-4,90 млн
1,04 млн
816,42 м.
EBT including unusual items
-8,46 млн
-20,18 млн
-4,28 млн
1,29 млн
EBT excluding unusual items
-8,46 млн
-20,31 млн
-4,28 млн
1,29 млн
Income tax expense
-
1,05 млн
-
425,14 м.
Effective tax rate
-
-5,21%
-
33,01%
Other operating expenses
921,96 м.
1,77 млн
110,93 м.
345,87 м.
Net income
-8,46 млн
-21,23 млн
-4,28 млн
862,76 м.
Net profit margin
-17 956,70%
-99 007,38%
-141,02%
19,86%
Earnings per share
-
-
-
-
Interest and investment income
234,16 м.
1,61 млн
87,21 мың
27,61 мың
Interest expense
-1,14 мың
-926,00
-711,00
-404,00
Net interest expenses
233,02 м.
1,61 млн
86,50 мың
27,20 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,89 млн
-22,13 млн
-5,03 млн
205,24 м.
Gain or loss from assets sale
-92,00
4,07 мың
14,90 мың
-106,38 м.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары